Genes & Diseases

Scope & Guideline

Connecting genetics to disease for transformative insights.

Introduction

Explore the comprehensive scope of Genes & Diseases through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Genes & Diseases in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2352-4820
PublisherKEAI PUBLISHING LTD
Support Open AccessYes
CountryChina
TypeJournal
Convergefrom 2014 to 2024
AbbreviationGENES DIS / Genes Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, DONGCHENG DISTRICT 100009, PEOPLES R CHINA

Aims and Scopes

The journal 'Genes & Diseases' focuses on the intersection of genetics and various diseases, emphasizing the molecular mechanisms underlying disease pathology and potential therapeutic interventions. It provides a platform for innovative research that integrates genomics, molecular biology, and clinical applications.
  1. Molecular Genetics and Disease Mechanisms:
    Research exploring the genetic basis of diseases, including the identification of mutations, polymorphisms, and their roles in disease progression.
  2. Transcriptional and Epigenetic Regulation:
    Studies on how transcriptional control and epigenetic modifications influence gene expression in the context of various diseases.
  3. Cancer Biology and Therapeutics:
    Investigations into the molecular mechanisms of cancer, including tumor microenvironment interactions, signaling pathways, and therapeutic targets.
  4. Immunology and Autoimmunity:
    Research on immune responses in disease states, including the role of immune checkpoints, inflammatory pathways, and autoimmune conditions.
  5. Stem Cell Biology and Regenerative Medicine:
    Exploration of stem cell mechanisms, differentiation, and their therapeutic applications in disease treatment and tissue regeneration.
  6. Metabolism and Disease:
    Studies on metabolic pathways and their alterations in diseases such as obesity, diabetes, and cancer, focusing on therapeutic implications.
  7. Neurobiology and Neurodegenerative Diseases:
    Research into the genetic and molecular underpinnings of neurodegenerative diseases, including Alzheimer's and Parkinson's disease.
  8. Infectious Diseases and Host Response:
    Investigations into the genetic factors affecting susceptibility to infectious diseases and the host's immune response mechanisms.
The journal 'Genes & Diseases' has been at the forefront of exploring new and innovative research themes. Recent publications indicate a significant shift towards several trending and emerging scopes that reflect the current landscape of biomedical research.
  1. Multi-Omics Approaches:
    There is a growing emphasis on integrating genomic, transcriptomic, proteomic, and metabolomic data to provide a comprehensive understanding of disease mechanisms and therapeutic targets.
  2. Precision Medicine and Personalized Therapies:
    Research focused on tailoring treatment strategies based on genetic and molecular profiling of patients is gaining traction, reflecting the shift towards individualized healthcare.
  3. Ferroptosis and Regulated Cell Death:
    Ferroptosis, a form of regulated cell death, is emerging as a significant area of research, particularly in its implications for cancer therapy and neurodegenerative diseases.
  4. Immunotherapy and Cancer Microenvironment:
    Studies exploring the interactions between cancer cells and the immune microenvironment, including the role of immune checkpoints and tumor-infiltrating lymphocytes, are increasingly prominent.
  5. Gene Editing Technologies:
    The application and implications of CRISPR and other gene editing technologies in treating genetic disorders and cancers are trending, highlighting their potential for future therapies.
  6. Role of Non-Coding RNAs in Disease:
    Research into the functions and mechanisms of long non-coding RNAs (lncRNAs) and circular RNAs in various diseases is on the rise, emphasizing their potential as biomarkers and therapeutic targets.
  7. Microbiome and Human Health:
    Explorations of the relationship between the microbiome and various diseases, including metabolic and autoimmune conditions, are becoming a significant focus.
  8. Neuroinflammation and Neurodegeneration:
    Research on the mechanisms of neuroinflammation and its role in neurodegenerative diseases is gaining importance, reflecting a broader understanding of brain health.

Declining or Waning

While 'Genes & Diseases' continues to expand its focus on various emerging themes, certain areas appear to be experiencing a decline in prominence. These waning scopes may reflect shifts in research priorities or advancements in scientific understanding.
  1. Traditional Genetic Association Studies:
    While genetic association studies remain important, there has been a noticeable shift toward more integrative approaches that combine genomics with other omics data, leading to a decline in standalone genetic association studies.
  2. Basic Mechanistic Studies Without Clinical Relevance:
    Research that focuses solely on basic mechanisms without a clear clinical application or relevance is becoming less frequent, as the journal prioritizes studies with translational potential.
  3. Single-Factor Analyses in Complex Diseases:
    There is a decrease in studies that analyze single genetic or molecular factors in complex diseases, with a growing preference for multi-factorial and systems biology approaches.
  4. Historical Reviews on Established Diseases:
    Reviews focusing on well-established diseases without new insights or perspectives are waning, as the journal seeks fresh, innovative content that addresses current research gaps.

Similar Journals

Cell Discovery

Elevating Knowledge in Cellular and Molecular Biology
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

MOLECULAR MEDICINE

Catalyzing Collaboration in Molecular Research
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

CELL RESEARCH

Unveiling the Mysteries of Cellular Mechanisms
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

CELL

Leading the charge in innovative biochemistry research.
Publisher: CELL PRESSISSN: 0092-8674Frequency: 26 issues/year

CELL is a premier academic journal in the field of Biochemistry, Genetics, and Molecular Biology, published by CELL PRESS. Founded in 1974, this esteemed journal has steadfastly contributed to advancing our understanding of cellular processes and organisms, making it integral for researchers and practitioners alike. With an impressive impact factor that places it in the Q1 category of its field, CELL ranks #1 out of 221 in general biochemistry and genetics, achieving a remarkable 99th percentile in Scopus rankings. Though it is not currently an open-access publication, the journal regularly disseminates high-quality research that impacts the scientific community significantly. Researchers, students, and professionals seeking to stay at the forefront of innovative discoveries and methodologies in molecular biology will find CELL an invaluable resource through its comprehensive articles and reviews.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Illuminating Cellular Processes Through Open Access Research
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

Frontiers in Bioscience-Landmark

Uncovering Landmark Research in Life Sciences
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

CELLULAR AND MOLECULAR LIFE SCIENCES

Fostering Breakthroughs in Cellular and Molecular Research
Publisher: SPRINGER BASEL AGISSN: 1420-682XFrequency: 24 issues/year

CELLULAR AND MOLECULAR LIFE SCIENCES, published by SPRINGER BASEL AG, stands as a premier journal dedicated to advancing the field of cellular and molecular biology. With an impressive 2023 impact factor reflected in its Q1 rankings across key categories—including Cell Biology, Molecular Biology, and Pharmacology—it serves as a critical platform for researchers aiming to disseminate high-quality findings in these dynamic fields. Operated under an open access framework, the journal allows broader accessibility to groundbreaking research, fostering collaboration amongst scientists globally. Based in Switzerland, CELLULAR AND MOLECULAR LIFE SCIENCES has been at the forefront of scientific publishing since 1952, adapting to contemporary scientific challenges and trends, ultimately shaping the future of life sciences.

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Advancing the Frontiers of Gene Expression Knowledge
Publisher: BEGELL HOUSE INCISSN: 1045-4403Frequency: 3 issues/year

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, published by BEGELL HOUSE INC, serves as a vital resource within the fields of Genetics and Molecular Biology. With the ISSN 1045-4403 and E-ISSN 2162-6502, this journal has been contributing to scientific discourse since 1990 and is projected to continue its publication until 2024. Despite its classification in the Q3 quartile for both Genetics and Molecular Biology, its impact on the research community is significant, as evidenced by its diverse range of critical reviews that synthesize and analyze emerging trends and foundational studies in gene expression. The journal, located in the United States at 50 North St, Danbury, CT 06810, offers a platform for researchers, professionals, and students to engage with innovative ideas and methodologies that drive forward the understanding of gene regulatory mechanisms in eukaryotes. Although it currently does not offer open access, the journal's content remains crucial for those dedicated to advancing knowledge in the intricacies of genetic expression.

CELL PROLIFERATION

Fostering Discoveries that Transform Biotechnology
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

JOURNAL OF MOLECULAR MEDICINE-JMM

Elevating the Standards of Molecular Medicine Research.
Publisher: SPRINGER HEIDELBERGISSN: 0946-2716Frequency: 12 issues/year

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.